APA

Koç O. N., Reese J. S., Davis B. M., Liu L., Majczenko K. J. & Gerson S. L. (19990622). DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. : Human gene therapy.

Chicago

Koç O N, Reese J S, Davis B M, Liu L, Majczenko K J and Gerson S L. 19990622. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. : Human gene therapy.

Harvard

Koç O. N., Reese J. S., Davis B. M., Liu L., Majczenko K. J. and Gerson S. L. (19990622). DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. : Human gene therapy.

MLA

Koç O N, Reese J S, Davis B M, Liu L, Majczenko K J and Gerson S L. DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts. : Human gene therapy. 19990622.